Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a…
Read More...
Read More...
